However, it is important to note that the spectrum of mutations of DDX3X differs between B-cell neoplasms and medulloblastoma (truncating mutations versus nonsynonymous single nucleotide changes) and the functional consequences of DLBCL/CLL-associated DDX3X mutations have not been reported. This evidence concerns the gene DDX3X and diffuse large B-cell lymphoma.